论文部分内容阅读
目的 评价低分子肝素治疗下肢深静脉血栓 (DVT)的临床疗效。方法 筛选我院及珠江医院收治的DVT患者 (1995年 3月～ 2 0 0 0年 3月 ) 90例分为治疗组 (6 0例 ,应用低分子肝素 )和对照组 (30例 ,静点前列腺素E1注射剂 )。两组患者均卧床 ,抬高患肢 ,口服肠溶阿司匹林片 80mg ,每日 1次。结果 治疗组总有效率为 85 % ,对照组总有效率为 5 5 % ,两组差异有非常显著性 (经 χ2 检验 ,P <0 .0 1) ,治疗组临床疗效优于对照组。结论 低分子肝素治疗DVT临床效果好 ,值得推广
Objective To evaluate the clinical efficacy of low molecular weight heparin in the treatment of deep vein thrombosis (DVT). Methods Ninety patients with DVT admitted from March 1995 to March 2000 in our hospital and Zhujiang Hospital were divided into treatment group (60 cases, low molecular weight heparin) and control group (30 cases) Prostaglandin E1 injection). Two groups of patients were in bed, raise the limbs, oral enteric-coated aspirin 80mg, 1 day. Results The total effective rate was 85% in the treatment group and 55% in the control group. There was significant difference between the two groups (χ2 test, P <0.01). The clinical efficacy of the treatment group was better than that of the control group. Conclusion Low molecular weight heparin is effective in treating DVT and is worth promoting